Gs. Wand et H. Schumann, RELATIONSHIP BETWEEN PLASMA ADRENOCORTICOTROPIN, HYPOTHALAMIC OPIOID TONE, AND PLASMA LEPTIN, The Journal of clinical endocrinology and metabolism, 83(6), 1998, pp. 2138-2142
The purpose of the present study was to further the understanding of t
he relationship between plasma leptin concentrations, hypothalamic opi
oid tone, and plasma ACTH secretory dynamics. ACTH(1-24) challenges (2
50 mu g) produced the expected increase in plasma cortisol levels but
did not alter plasma leptin levels. Activation of the entire hypothala
mic-pituitary-adrenal (HPA) axis was induced by employing the opioid r
eceptor antagonist, naloxone. By blocking opioidergic inhibitory input
to hypothalamic CRH neurons, naloxone induced the expected increase i
n plasma ACTH and cortisol. Plasma ACTH levels peaked 30 min after nal
oxone administration, whereas plasma cortisol levels peaked 60 min aft
er opioid receptor blockade. Once again, plasma leptin concentrations
were not altered by this manipulation. However, there was a positive c
orrelation between fasting, integrated plasma leptin concentrations, a
nd plasma ACTH responses to naloxone (peak r = 0.822, P < 0.0001; and
area under curve r = 0.832, P < 0.0001). The correlation was stronger
when leptin was normalized to body mass index and expressed as the lep
tin/body mass index ratio (peak r = 0.878, P < 0.00001; and area under
curve r = 0.882, P < 0.00001). In summary, these findings indicate th
at activation of the HPA axis does not acutely alter plasma leptin con
centrations. However, plasma leptin levels may influence hypothalamic
opioidergic tone and thus modulate the magnitude of CRH release. The a
cute interaction of the HPA axis and leptin is unidirectional.